PLoS ONE 10:e0132744 Pal S, Maurya SK, Chattopadhyay S, Pal China S, Porwal K, Kulkarni C, Sanyal S, Sinha RA, Chattopadhyay N (2019) The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts
Purpose-built for physicians GLP-1s may reduce cardiovascular risk in rheumatoid arthritis treated with JAK inhibitors GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors, according to data presented at the EULAR 2025 Congress
Paradoxically, healthy sleep habits play a key role in neutralizing free radicals and managing oxidative stress
I even give subscriptions to family members because I believe in what Consumer Lab does
On April 1, 2026, the FDA approved Eli Lillys FOUNDAYO (orforglipron) , the second oral GLP-1 approved for obesity, and arguably the one with the more patient-friendly convenience profile